84 related articles for article (PubMed ID: 7530772)
1. Expression of a developmentally regulated epitope on fibronectins from the synovial fluid of patients with rheumatic disease.
Carsons S; Clausen H; Wolf J
J Rheumatol; 1994 Oct; 21(10):1888-91. PubMed ID: 7530772
[TBL] [Abstract][Full Text] [Related]
2. Enhanced expression of a peanut agglutinin reactive O linked oligosaccharide on fibronectins from the synovial fluid of patients with rheumatic disease: quantitation, domain localization, and functional significance.
Carsons S
J Rheumatol; 2002 May; 29(5):896-902. PubMed ID: 12022346
[TBL] [Abstract][Full Text] [Related]
3. Carbohydrate heterogeneity of fibronectins. Synovial fluid fibronectin resembles the form secreted by cultured synoviocytes but differs from the plasma form.
Carsons S; Lavietes BB; Slomiany A; Diamond HS; Berkowitz E
J Clin Invest; 1987 Nov; 80(5):1342-9. PubMed ID: 3680500
[TBL] [Abstract][Full Text] [Related]
4. Presence of ED-A containing fibronectin in human articular cartilage from patients with osteoarthritis and rheumatoid arthritis.
Chevalier X; Claudepierre P; Groult N; Zardi L; Hornebeck W
J Rheumatol; 1996 Jun; 23(6):1022-30. PubMed ID: 8782135
[TBL] [Abstract][Full Text] [Related]
5. Detection and quantitation of stem cell factor (kit ligand) in the synovial fluid of patients with rheumatic disease.
Carsons SE; Santiago-Schwarz F; Diola C
J Rheumatol; 2000 Dec; 27(12):2798-800. PubMed ID: 11128666
[TBL] [Abstract][Full Text] [Related]
6. Citrullination of fibronectin in rheumatoid arthritis synovial tissue.
Chang X; Yamada R; Suzuki A; Kochi Y; Sawada T; Yamamoto K
Rheumatology (Oxford); 2005 Nov; 44(11):1374-82. PubMed ID: 16105911
[TBL] [Abstract][Full Text] [Related]
7. Functional analysis of rheumatoid factor-producing B cells from the synovial fluid of rheumatoid arthritis patients.
Reparon-Schuijt CC; van Esch WJ; van Kooten C; Levarht EW; Breedveld FC; Verweij CL
Arthritis Rheum; 1998 Dec; 41(12):2211-20. PubMed ID: 9870878
[TBL] [Abstract][Full Text] [Related]
8. Synovial fibronectin fragmentation and domain expressions in relation to rheumatoid arthritis progression.
Przybysz M; Borysewicz K; Szechinski J; Katnik-Prastowska I
Rheumatology (Oxford); 2007 Jul; 46(7):1071-5. PubMed ID: 17459959
[TBL] [Abstract][Full Text] [Related]
9. Cancer-associated changes in glycosylation of fibronectin. Immunohistological localization of oncofetal fibronectin defined by monoclonal antibodies.
Mandel U; Hamilton Therkildsen M; Reibel J; Sweeney B; Matsuura H; Hakomori S; Dabelsteen E; Clausen H
APMIS; 1992 Sep; 100(9):817-26. PubMed ID: 1389100
[TBL] [Abstract][Full Text] [Related]
10. Oncofetal fibronectins in oral carcinomas: correlation of two different types.
Mandel U; Gaggero B; Reibel J; Therkildsen MH; Dabelsteen E; Clausen H
APMIS; 1994 Sep; 102(9):695-702. PubMed ID: 7946273
[TBL] [Abstract][Full Text] [Related]
11. Preferential recognition of a fragment species of osteoarthritic synovial fluid fibronectin by antibodies to the alternatively spliced EIIIA segment.
Peters JH; Carsons S; Kalunian K; McDougall S; Yoshida M; Ko F; van der Vliet-Hristova M; Hahn TJ
Arthritis Rheum; 2001 Nov; 44(11):2572-85. PubMed ID: 11710714
[TBL] [Abstract][Full Text] [Related]
12. Differential expression of chemokine receptors on peripheral blood, synovial fluid, and synovial tissue monocytes/macrophages in rheumatoid arthritis.
Katschke KJ; Rottman JB; Ruth JH; Qin S; Wu L; LaRosa G; Ponath P; Park CC; Pope RM; Koch AE
Arthritis Rheum; 2001 May; 44(5):1022-32. PubMed ID: 11352233
[TBL] [Abstract][Full Text] [Related]
13. Electrophoretic characterization of species of fibronectin bearing sequences from the N-terminal heparin-binding domain in synovial fluid samples from patients with osteoarthritis and rheumatoid arthritis.
Peters JH; Carsons S; Yoshida M; Ko F; McDougall S; Loredo GA; Hahn TJ
Arthritis Res Ther; 2003; 5(6):R329-39. PubMed ID: 14680507
[TBL] [Abstract][Full Text] [Related]
14. Discrepancy between mRNA and protein expression of tumour suppressor maspin in synovial tissue may contribute to synovial hyperplasia in rheumatoid arthritis.
Schedel J; Distler O; Woenckhaus M; Gay RE; Simmen B; Michel BA; Müller-Ladner U; Gay S
Ann Rheum Dis; 2004 Oct; 63(10):1205-11. PubMed ID: 15361372
[TBL] [Abstract][Full Text] [Related]
15. An alpha-N-acetylgalactosaminylation at the threonine residue of a defined peptide sequence creates the oncofetal peptide epitope in human fibronectin.
Matsuura H; Greene T; Hakomori S
J Biol Chem; 1989 Jun; 264(18):10472-6. PubMed ID: 2471705
[TBL] [Abstract][Full Text] [Related]
16. The oncofetal domain of fibronectin defined by monoclonal antibody FDC-6: its presence in fibronectins from fetal and tumor tissues and its absence in those from normal adult tissues and plasma.
Matsuura H; Hakomori S
Proc Natl Acad Sci U S A; 1985 Oct; 82(19):6517-21. PubMed ID: 2995969
[TBL] [Abstract][Full Text] [Related]
17. Monoclonal antibodies that distinguish between human cellular and plasma fibronectin.
Keen J; Chang SE; Taylor-Papadimitriou J
Mol Biol Med; 1984 Feb; 2(1):15-27. PubMed ID: 6083431
[TBL] [Abstract][Full Text] [Related]
18. Alternatively spliced CS-1 fibronectin isoform and its receptor VLA-4 in rheumatoid arthritis synovium.
Müller-Ladner U; Elices MJ; Kriegsmann JB; Strahl D; Gay RE; Firestein GS; Gay S
J Rheumatol; 1997 Oct; 24(10):1873-80. PubMed ID: 9330926
[TBL] [Abstract][Full Text] [Related]
19. Fibronectin fragments in osteoarthritic synovial fluid.
Xie DL; Meyers R; Homandberg GA
J Rheumatol; 1992 Sep; 19(9):1448-52. PubMed ID: 1433014
[TBL] [Abstract][Full Text] [Related]
20. Soluble Fas ligand in the joints of patients with rheumatoid arthritis and osteoarthritis.
Hashimoto H; Tanaka M; Suda T; Tomita T; Hayashida K; Takeuchi E; Kaneko M; Takano H; Nagata S; Ochi T
Arthritis Rheum; 1998 Apr; 41(4):657-62. PubMed ID: 9550474
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
